1. Home
  2. DAKT vs AQST Comparison

DAKT vs AQST Comparison

Compare DAKT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$19.20

Market Cap

872.1M

Sector

Industrials

ML Signal

HOLD

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$5.81

Market Cap

809.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
AQST
Founded
1968
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
872.1M
809.3M
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
DAKT
AQST
Price
$19.20
$5.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$26.00
$10.00
AVG Volume (30 Days)
415.5K
2.4M
Earning Date
12-10-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$770,283,000.00
$43,397,000.00
Revenue This Year
$12.94
N/A
Revenue Next Year
$7.16
$52.69
P/E Ratio
$128.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.24
$2.12
52 Week High
$24.38
$7.55

Technical Indicators

Market Signals
Indicator
DAKT
AQST
Relative Strength Index (RSI) 52.50 43.84
Support Level $18.58 $5.99
Resistance Level $21.28 $6.44
Average True Range (ATR) 0.88 0.32
MACD 0.17 -0.03
Stochastic Oscillator 50.45 11.37

Price Performance

Historical Comparison
DAKT
AQST

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: